Masimo (NSDQ:MASI) this week posted third-quarter results that beat the overall consensus forecast on Wall Street. The Irvine, California-based monitoring technology company reported profits of $57.8 million, or $1.00 per share, on sales of $307.4 million, for the three months ended October 2, for a bottom-line gain of 17% on sales growth of 10.5% compared with […]
Patient Monitoring
LifeScan launches digital diabetes management platform
LifeScan announced today that it launched its OneTouch solutions offering wellness programs to help people manage their diabetes. Malvern, Pennsylvania–based LifeScan made its OneTouch solutions available to consumers in the U.S. now and plans to soon offer it to healthcare providers, payors and employers as a reimbursed adjudicated option in early 2022. Get the full story […]
Ultrahuman hires chief business officer as it scales expansion for glucose monitoring tech
Metabolic tracking technology developer Ultrahuman announced today that it appointed Bhuvan Srinivasan as its first chief chief business officer. The appointment of Srinivasan to the new role follows Bangalore, India-based Ultrahuman’s $17.5 million Series B financing round completed in August. Get the full story at our sister site, Drug Delivery Business News.
Massachusetts offers Medicaid coverage for Pear Therapeutics’ digital therapeutics
Pear Therapeutics announced today that MassHealth intends to cover the company’s prescription digital therapeutics (PDTs). MassHealth — Massachusetts’ Medicaid program — notified Pear of its plans to cover the FDA-authorized reSET and reSET-O PDTs for treating substance use disorder and opioid use disorder, respectively. The decision remains subject to certain customary conditions, including federal and […]
Dexcom announces Garmin as first partner for real-time APIs
Dexcom (NYSE:DXCM) announced today that Garmin introduced its Dexcom Connect IQ apps on its smartwatch and cycling computer. Garmin today launched the apps to provide people using the Dexcom G7 continuous glucose monitor (CGM) with Type 1 and Type 2 diabetes a way to quickly see glucose levels and trends, even while working out. Apps compatible […]
Metabolic disease reversal tech company Twin Health raises $140M Series C
Twin Health announced that it raised $140 million in a Series C financing round as it scales its service in the U.S. and globally. Mountain View, California-based Twin Health develops the Whole Body Digital Twin platform designed to help reverse and prevent chronic metabolic diseases while improving energy and health. Get the full story at our […]
Masimo officials think their tech could reduce healthcare worker burnout
Masimo (NSDQ:MASI) announced today that University Hospitals (UH) of Cleveland is using its Masimo Patient SafetyNet system. Irvine, California–based Masimo’s Patient SafetyNet remote monitoring and supplemental alarm system could combat nurse burnout by improving workflows and reducing workloads, according to a news release. Such burnout has been a topic of interest amid the latest surge […]
Medtronic points to study showing that multi-hour AFib increases stroke risks
Medtronic (NYSE:MDT) announced today that a study using its continuous rhythm monitoring device showed AFib’s relationship with ischemic stroke. Fridley, Minnesota–based Medtronic’s data covers 466,635 patients included in the Optum unidentified electronic health record (EHR) and Medtronic CareLink databases. Findings were published online in JAMA Cardiology, according to a news release. Of the large population of […]
Hillrom’s business outlook is better-than-expected as Baxter prepares to acquire
Analysts are pleased with Hillrom’s (NYSE:HRC) position following a proxy statement last week as it nears its merger with Baxter (NYSE:BAX). Baxter announced last month that it agreed to buy Hillrom for approximately $12.4 billion, with Hillrom shareholders set to receive $156 per common stock share as the company will survive the merger as a […]
Insulet reports positive study results for Omnipod 5
Insulet (NSDQ:PODD) last week presented positive pivotal trial data for its Omnipod 5 automated insulin delivery system. Acton, Massachusetts-based Insulet’s Omnipod 5 — which it touts as the world’s first tubeless wearable system for continuously adapting insulin delivery based on glucose levels and trends — significantly improved time in range and reduced HbA1c in the trial. […]
Welldoc wins expanded FDA clearance for BlueStar insulin dosing platform
Welldoc announced today that it received another FDA 510(k) clearance for its BlueStar diabetes treatment platform. Columbia, Maryland-based Welldoc’s new clearance for BlueStar — the ninth in total — expands insulin dosing support to most types of insulin, including bolus and premixed insulin titration for type 2 diabetes. Get the full story at our sister site, […]